Novome Biotechnologies, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.novomebio.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects
Phase 1
Terminated
- Conditions
- Healthy VolunteersEnteric Hyperoxaluria
- Interventions
- First Posted Date
- 2021-06-02
- Last Posted Date
- 2023-05-17
- Lead Sponsor
- Novome Biotechnologies Inc
- Target Recruit Count
- 153
- Registration Number
- NCT04909723
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
🇺🇸Advanced Urology Institute, Daytona Beach, Florida, United States
News
No news found